{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3754, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "before_after", "function": "analyze_data", "notes": "The chart uses a stacked bar approach to show the components of FX impact.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/27", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-27", "loopMatches": [ { "to": 27, "from": 25, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "bd0edf59-9927-49bc-9090-e7b272ce8db8", "evidence": "Operating margin contraction driven by LAC and foreign exchange benefit on operating profit", "position": 1, "objective": "Showing the impact of operating margin contraction and foreign exchange", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.6, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 33, "from": 19, "beatId": "465dfddd-4c62-4ec4-ab1d-9f59e6aba572", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Robust action plan and outlook for future growth", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a standard financial reporting table format to highlight debt metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/28", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 33, "from": 19, "beatId": "465dfddd-4c62-4ec4-ab1d-9f59e6aba572", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Robust action plan and outlook for future growth", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "other", "function": "plan_implementation", "notes": "The slide uses a house-like structure to represent the capital allocation framework.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/29", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 33, "from": 19, "beatId": "465dfddd-4c62-4ec4-ab1d-9f59e6aba572", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Robust action plan and outlook for future growth", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The chart uses a standard waterfall bridge to decompose the change in EPS.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/30", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 33, "from": 19, "beatId": "465dfddd-4c62-4ec4-ab1d-9f59e6aba572", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Robust action plan and outlook for future growth", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/31", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 33, "from": 19, "beatId": "465dfddd-4c62-4ec4-ab1d-9f59e6aba572", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Robust action plan and outlook for future growth", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/32", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 33, "from": 19, "beatId": "465dfddd-4c62-4ec4-ab1d-9f59e6aba572", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Robust action plan and outlook for future growth", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a hierarchical structure to connect high-level purpose to operational execution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/33", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 33, "from": 19, "beatId": "465dfddd-4c62-4ec4-ab1d-9f59e6aba572", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Robust action plan and outlook for future growth", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/34", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table uses a waterfall-style logic to bridge operating profit figures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/35", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_disclosure", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/36", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_disclosure", "function": "appendix", "notes": "This is a continuation of a financial disclosure page from a Diageo interim results report.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/37", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_methodology", "function": "other", "notes": "This slide is part of a series of methodological disclosures, likely from an annual or interim report.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/38", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-99e1-76a2-8cd7-c07e5c328fe4", "docSlug": "9f13a5aedd4ebc4f5bcff16426f23d48", "documentTitle": "Diageo | Results Presentation Deck | 39 slides", "authorId": "diageo", "authorName": "Diageo", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "appendix_methodology", "function": "appendix", "notes": "This is a continuation of a methodology disclosure page.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-99e1-76a2-8cd7-c07e5c328fe4/39", "deckHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4", "deckAnchorHref": "/decks/019de076-99e1-76a2-8cd7-c07e5c328fe4#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Features imagery from EA Sports titles (NHL, UFC, WRC).", "imagePath": "https://imgproxy.kitesheet.com/dyz27B-PVA1s4pLeox8iFnutr33S-GXbVudFUyd6Svs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85OTkxMmE0MTgwZDc2NjAyZDUzODUyMDY2Zjc2YTVmYi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/1", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/3kuVsNIbEf4PrH4jVzqHqMDlZskWdSol0YrsqDIX-bQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85OTkxMmE0MTgwZDc2NjAyZDUzODUyMDY2Zjc2YTVmYi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/5dxijuUwlWKFovFElqISeODuAtUcmigXTQR4RRZSEVQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85OTkxMmE0MTgwZDc2NjAyZDUzODUyMDY2Zjc2YTVmYi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/A2IMxq0v4tu12aYiYCAw_s01VaWUL5eTIXpf0WuX9AQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85OTkxMmE0MTgwZDc2NjAyZDUzODUyMDY2Zjc2YTVmYi9wMDAxLnBuZw" }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/2", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/3", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a 2x3 grid layout to present key performance indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/4", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-4", "loopMatches": [ { "to": 7, "from": 4, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "e09fb2d6-fdc3-4b67-9634-5832ff27fa47", "evidence": "The presentation of Net Bookings by Composition and Platform", "position": 0, "objective": "To show financial performance against benchmarks", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 7, "from": 4, "beatId": "641f2c06-6f95-452c-a200-319ff29658ba", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-1", "evidence": "The first section presents current financial KPIs", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses stacked bar charts to show revenue composition over three periods (Q3 FY22-FY24).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/5", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-5", "loopMatches": [ { "to": 7, "from": 4, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "e09fb2d6-fdc3-4b67-9634-5832ff27fa47", "evidence": "The presentation of Net Bookings by Composition and Platform", "position": 0, "objective": "To show financial performance against benchmarks", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 7, "from": 4, "beatId": "641f2c06-6f95-452c-a200-319ff29658ba", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-1", "evidence": "The first section presents current financial KPIs", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes YoY and YoY constant currency (CC) growth metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/6", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-6", "loopMatches": [ { "to": 7, "from": 4, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "e09fb2d6-fdc3-4b67-9634-5832ff27fa47", "evidence": "The presentation of Net Bookings by Composition and Platform", "position": 0, "objective": "To show financial performance against benchmarks", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 7, "from": 4, "beatId": "641f2c06-6f95-452c-a200-319ff29658ba", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-1", "evidence": "The first section presents current financial KPIs", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a legend to distinguish between annual full game releases and new title releases in FY24.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/7", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-7", "loopMatches": [ { "to": 7, "from": 4, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "e09fb2d6-fdc3-4b67-9634-5832ff27fa47", "evidence": "The presentation of Net Bookings by Composition and Platform", "position": 0, "objective": "To show financial performance against benchmarks", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 7, "from": 4, "beatId": "641f2c06-6f95-452c-a200-319ff29658ba", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-1", "evidence": "The first section presents current financial KPIs", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes specific disclaimers regarding EPS calculation and asset impairment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/8", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "summarize", "notes": "Includes a stylized character illustration on the right side.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/9", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-9", "loopMatches": [ { "to": 9, "from": 9, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "feda117a-99d9-4582-a40e-da8356b5d1a4", "evidence": "The section on 2023: Year in Gaming", "position": 1, "objective": "To explain the current state of the gaming industry", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 9, "from": 9, "beatId": "b3ef1aaa-6a1f-4b6f-b5ac-5369e9ac6331", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "What Is", "beatSlug": "sparkline-what-is-3", "evidence": "A summary of the year in gaming", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/10", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table provides a reconciliation of GAAP guidance to adjusted figures for the three months ending March 31, 2024.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/11", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table reconciles GAAP guidance ranges with specific non-GAAP adjustments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/12", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes definition of Free Cash Flow in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/13", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides specific FX rate assumptions for EUR, GBP, CAD, and SEK for Q3 2023, Q3 2024, and Q4E 2024, along with sensitivity analysis for a 10% USD strengthening.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/14", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents two separate tables: one for Q4 and one for the full year, detailing the impact of currency on year-over-year growth rates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/15", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes two separate tables: one by platform (Console, PC, Mobile) and one by product type (Full game, Live services).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/16", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9a79-735b-869f-b1b02e3ae2c1", "docSlug": "99912a4180d76602d53852066f76a5fb", "documentTitle": "Electronic Arts | Results Presentation Deck | 17 slides", "authorId": "electronic-arts", "authorName": "Electronic Arts", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard financial disclosure slide for Electronic Arts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9a79-735b-869f-b1b02e3ae2c1/17", "deckHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1", "deckAnchorHref": "/decks/019de076-9a79-735b-869f-b1b02e3ae2c1#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 17, "from": 8, "beatId": "b501fb12-fc70-45a2-8bab-8f574c95f8bf", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Guidance and detailed financial data", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/zYhxC5TCpgjaK6BnJGY8WmUcvu5OxraZ5GxRhIsxLeo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMGZjZmViYmY1YmE3YzM0YzJkNGFlYzdlM2IwNWVkNi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/1", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/05zMc1LnlE5DF7ide0MmynhocesdCcikBQUOBGwSiI0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMGZjZmViYmY1YmE3YzM0YzJkNGFlYzdlM2IwNWVkNi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/_cWPrvHThHNEYahkg2EcmM_R4s60tduBbygNur7QKpc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMGZjZmViYmY1YmE3YzM0YzJkNGFlYzdlM2IwNWVkNi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/IlbCwLiM2klMwznvrHu8L21rejxxGOSrbAhx9d2vkJQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMGZjZmViYmY1YmE3YzM0YzJkNGFlYzdlM2IwNWVkNi9wMDAxLnBuZw" }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/2", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "vision", "function": "inspire_vision", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/3", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a structured layout to present market data for three distinct cancer segments, including CAGR and projected market values.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/4", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-4", "loopMatches": [ { "to": 6, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "1a0c31bd-83b1-44a2-a585-7a9095367a87", "evidence": "The presentation logically connects the market opportunity to RENB-DC11's potential.", "position": 0, "objective": "What is the market opportunity for RENB-DC11?", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.8, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "97f93e02-4861-4e2d-a328-40b8053f0e8c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The presentation identifies the problem of solid tumors and the need for effective treatment.", "position": 0, "confidence": 0.9, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/5", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-5", "loopMatches": [ { "to": 6, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "1a0c31bd-83b1-44a2-a585-7a9095367a87", "evidence": "The presentation logically connects the market opportunity to RENB-DC11's potential.", "position": 0, "objective": "What is the market opportunity for RENB-DC11?", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.8, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "97f93e02-4861-4e2d-a328-40b8053f0e8c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The presentation identifies the problem of solid tumors and the need for effective treatment.", "position": 0, "confidence": 0.9, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "traction", "function": "show_traction", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/6", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-6", "loopMatches": [ { "to": 6, "from": 4, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "1a0c31bd-83b1-44a2-a585-7a9095367a87", "evidence": "The presentation logically connects the market opportunity to RENB-DC11's potential.", "position": 0, "objective": "What is the market opportunity for RENB-DC11?", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.8, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "traction", "function": "show_traction", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/7", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/8", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "context", "function": "establish_context", "notes": "Scientific diagram illustrating the mechanism of antigen presentation and T cell maturation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/9", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a biological diagram to explain the 'problem' of immune evasion in cancer therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/10", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-10", "loopMatches": [ { "to": 11, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "571b0175-2fef-4963-89a8-c0cbb11eeb35", "evidence": "The presentation highlights the challenge of treating solid tumors and the need for effective treatment.", "position": 1, "objective": "What is the cost of not treating solid tumors effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 10, "from": 10, "beatId": "fe0bf248-9ab2-47f5-90c7-56fb31f6cb32", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation explains how tumor cells evade the normal immune response, making treatment challenging.", "position": 1, "confidence": 0.9, "parentBeatName": "Development", "parentBeatSlug": "development" }, { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "solution", "function": "present_solution", "notes": "The diagram uses a funnel-like or layered process flow to map biological mechanisms to specific immune outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/11", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-11", "loopMatches": [ { "to": 11, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "571b0175-2fef-4963-89a8-c0cbb11eeb35", "evidence": "The presentation highlights the challenge of treating solid tumors and the need for effective treatment.", "position": 1, "objective": "What is the cost of not treating solid tumors effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a process flow diagram to illustrate the 8-step manufacturing timeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/12", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a red border to highlight the RENB-DC11 row as the superior alternative.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/13", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "customer_journey", "function": "present_framework", "notes": "The diagram illustrates a complex supply chain process involving biopsy, manufacturing, and clinical administration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/14", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a combination of a process diagram and dot plots to validate the model's performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/15", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The slide presents two bar charts (weight and volume) and a grid of tumor photographs as visual proof of concept.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/16", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "Includes visual evidence of tumor size alongside quantitative bar charts with statistical significance markers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/17", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "The table shows 0/3 incidence of metastasis/ascites in the RENB-DC11 group compared to high incidence in control groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/18", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "solution", "function": "analyze_data", "notes": "The slide presents two bar charts comparing control, tumor, tumor+mock, and tumor+TD groups under different treatment conditions (IL2 vs aCD16).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/19", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "N=2-3 sample size indicated at bottom left.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/20", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The slide demonstrates efficacy of RENB-DC11 in stimulating immune response (IFNg production) in a tumor model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/21", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "The slide uses immunohistochemistry (brown staining) to visualize CD4+ T-cells, quantified in the bar chart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/22", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "traction", "function": "show_traction", "notes": "The slide uses immunohistochemistry images and a corresponding bar chart to demonstrate efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/23", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 23, "from": 6, "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.", "position": 3, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "other", "function": "present_solution", "notes": "This is a standard TPP (Target Product Profile) table used in biotech/pharma pitch decks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/24", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a clinical development plan with specific milestones for 2025 and 2026, focusing on safety and efficacy cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/25", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "solution", "function": "present_solution", "notes": "The slide contrasts the traditional CRO outsourcing model with a direct management model to justify cost efficiency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/26", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard corporate legal disclosure slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/27", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9b15-737c-b05c-8347f7a98ad7", "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6", "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides", "authorId": "enochian-biosciences", "authorName": "Renovaro Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/28", "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7", "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 5, "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.", "position": 2, "confidence": 0.9, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/3MGl-4jFgArtYZrqT4a00mKAALmsCk51bAtZ7yhB3a4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MGNhMGI5M2ZjYzVjOTQyNTcwNTUzOWI5ZTZmY2NjYi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/1", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "7c14303c-7cf7-4655-a29d-3b1346ff20bb", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to Erasca's vision and pipeline", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": "https://imgproxy.kitesheet.com/xSDGgOmyCvSE2QJQTD-FIUT14wa4XRbzUHiJzMVJ6dw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MGNhMGI5M2ZjYzVjOTQyNTcwNTUzOWI5ZTZmY2NjYi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/3sARyMfEgNSuoQ-yFKqDrTTLxfiOoA6eUxcbubkmNgI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MGNhMGI5M2ZjYzVjOTQyNTcwNTUzOWI5ZTZmY2NjYi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/DECtmh_GqUr5QP1zQ9LenMphxMrxxhXLRpCddEv2u6E/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81MGNhMGI5M2ZjYzVjOTQyNTcwNTUzOWI5ZTZmY2NjYi9wMDAxLnBuZw" }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/2", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "7c14303c-7cf7-4655-a29d-3b1346ff20bb", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to Erasca's vision and pipeline", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }